Health Condition 1: F488- Other specified nonpsychotic mental disorders
Conditions
Interventions
Intervention1: Habbe Jadwar Kochak: 125 mg Orally twice daily to be taken with water for 6 weeks
Control Intervention1: Nil: Nil
Sponsors
Central Council for Research in Unani Medicine CCRUM New Delhi
Eligibility
Inclusion criteria
Inclusion criteria: The patients fulfilling the following criteria will be included in this study: 1. Patients of either sex in the age group 40-65 years. 2. Patients of á¸?uâ??f al-DimÄ?gh (Cerebro-asthenia) having subjective complaints of cognitive impairment: a. Memory loss b. Mild headache c. Anxiety d. ButlÄ?n-i-Takallum (Speech impairment) e. ButlÄ?n-i-TahrÄ«r (Writing impairment) 3. MMSE score of 10-23 representing mild to moderate cognitive impairment
Exclusion criteria
Exclusion criteria: The patients having any of the following criteria will be excluded from the study: 1. Clinical presentation and/or history of any significant organic neurological diseases including space occupying lesions, stroke, head injury, seizure, and mental retardation. 2. Secondary causes of dementia including hypothyroidism or hyperthyroidism. 3. Known cases of B12 vitamin deficiencies. 4. Clinical presentation and known case of a chronic disease that requires long-term treatment. 5. Patients on Psychotropic Drugs 6. H/o alcohol or substance abuse or dependence. 7. H/o Hypersensitivity to the study drug or any of its ingredients 8. Pregnant and lactating women
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Improvement in sign and symptoms of á¸?uâ??f al-DimÄ?gh (Cerebro-asthenia)Timepoint: 6 Weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| Haematological and biochemical assessment for safety assessmentTimepoint: Investigations will be done at baseline and after every two weeks | — |
Countries
India
Contacts
Public ContactDr Pradeep Kumar
Central Council for Research in Unani Medicine (CCRUM)
Outcome results
None listed